$KMPH Voted Yes on RS with 100k+ shares. KP415 is going to be the next bloxkbuster ADHD drug because it has the same team behind it as $2bil/year Vyvanse. Want a broader buying pool to be able to boost stock price heading into PDUFA. They also may not even use a RS. Corium/GPC are throwing big money behind KP415 commercialization. Big BO potential as well. Should be 4-5× the market cap it is now by next Feb.
  • 6
6 Likes